Ancera Lands $1,093,998 New Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    21 Business Park Drive Branford, CT 06405 USA
  • Company Description
    The company is developing a rapid, portable technology platform for the separation, quantitative detection and identification of minute concentrations of various pathogens from whole blood or other bodily fluids. Ancera’s platform is based on technology it is licensing exclusively from Yale University.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 2 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy